Thông tin thuốc gốc
Chỉ định và Liều dùng
Adult: >17 yr As 0.1% cream: Apply a pea-sized amount to lightly cover the entire face (may include the eyelids) once daily at bedtime.

Mild to moderate plaque psoriasis
Adult: >18 yr As 0.05 or 0.1% cream/gel: Apply a thin layer to the affected lesion(s) once daily in the evening. Initiate at a strength of 0.05% then increase to 0.1% as tolerated. If drying or irritation occurs, apply a moisturiser at least 1 hr before admin of tazarotene. Usual duration of therapy: 12 wk (up to 12 mth if necessary).

Acne vulgaris
Adult: As 0.1% cream/foam: Apply a thin layer to cover the entire affected area(s) once daily in the evening. May use moisturiser as needed. Usual duration of therapy: 12 wk.
Child: ≥12 yr Same as adult dose.
Chống chỉ định
Patient w/ eczema and sunburn. Application to psoriatic lesions >10-20% of BSA. Pregnancy and lactation.
Thận trọng
Patient w/ history of skin cancer.
Phản ứng phụ
Significant: Desquamation, pruritus, skin redness, stinging/burning sensation, worsening of psoriasis, swelling at/near application sites, skin discoloration (hyper/hypopigmentation), skin exfoliation and inflammation, hypersensitivity (e.g. urticaria), photosensitivity.
CV: Peripheral oedema.
Endocrine: Hypertriglyceridaemia.
Dermatologic: Erythema, irritation, dermatitis, rash.
Thông tin tư vấn bệnh nhân
Do not use occlusive dressings. Avoid contact w/ inflamed skin, intertriginous areas, hair-covered scalp, eyes, mouth, and other mucous membranes. Avoid exposure to sunlight or other UV rays.
Perform pregnancy test w/in 2 wk prior to initiation of therapy and start treatment during a menstrual period.
Tương tác
Increased photosensitivity w/ drugs known to be photosensitisers (e.g. fluoroquinolones, tetracyclines, thiazide diuretics, sulfonamides, phenothiazines). Increased risk of irritation w/ use of topical medications and cosmetics w/ irritant or strong drying effects.
Tác dụng
Description: Tazarotene, a synthetic acetylenic retinoid, is a prodrug which is converted to tazarotenic acid then binds to 3 retinoic acid receptors but has relative selectivity for RARβ and RARγ. It regulates gene expression, thus modulating cell proliferation, differentiation, and hyperplasia.
Distribution: Plasma protein binding: highly bound as tazarotenic acid (>99%).
Metabolism: Metabolised via esterase hydrolysis to tazarotenic acid and via oxidation to inactive sulfoxides, sulfones, and other polar metabolites.
Excretion: Via urine and faeces. Elimination half-life: Approx 18 hr.
Đặc tính

Chemical Structure Image

Source: National Center for Biotechnology Information. PubChem Database. Tazarotene, CID=5381, https://pubchem.ncbi.nlm.nih.gov/compound/Tazarotene (accessed on Jan. 23, 2020)

Bảo quản
Store between 20-25°C. Do not freeze. Protect from heat.
Phân loại ATC
D05AX05 - tazarotene ; Belongs to the class of other antipsoriatics for topical use.
Avage Cream (Allergan, Inc.). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 13/11/2017.

Buckingham R (ed). Tazarotene. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 10/11/2017.

Fabior Aerosol (Mayne Pharma LLC). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 10/11/2017.

Joint Formulary Committee. Tazarotene. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 10/11/2017.

McEvoy GK, Snow EK, Miller J et al (eds). Tazarotene (Topical). AHFS Drug Information (AHFS DI) [online]. American Society of Health-System Pharmacists (ASHP). https://www.medicinescomplete.com. Accessed 10/11/2017.

Tazorac Cream (Allergan, Inc.). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 10/11/2017.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Tazarotene từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2021 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com
  • Glentaz
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in